First, a large number of literatures suggest that CD44, CD117, CD133, CD24, aldehyde dehydrogenase (ALDH) and other markers can be used to investigate cancer stem cells in certain ovarian cancer types. This evidence concerns the gene CD24 and ovarian cancer.